Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 351,005 | 285,719 | 284,466 | 224,002 | 241,200 |
| Receivables | 174,249 | 177,117 | 179,142 | 181,100 | 171,532 |
| Inventories | 285,830 | 289,207 | 259,379 | 255,756 | 254,680 |
| TOTAL | $865,744 | $801,607 | $769,722 | $706,309 | $715,789 |
| Non-Current Assets | |||||
| PPE Net | 307,766 | 304,467 | 310,885 | 313,138 | 307,844 |
| Intangibles | 715,909 | 734,056 | 742,002 | 750,495 | 757,582 |
| Other Non-Current Assets | 121,856 | 122,128 | 112,216 | 108,124 | 83,897 |
| TOTAL | $1,145,531 | $1,160,651 | $1,165,103 | $1,171,757 | $1,149,323 |
| Total Assets | $2,011,275 | $1,962,258 | $1,934,825 | $1,878,066 | $1,865,112 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 80,160 | 78,134 | 63,929 | 63,769 | 61,484 |
| Accrued Expenses | 45,638 | 32,970 | 64,475 | 52,182 | 44,596 |
| Other current liabilities | 124,851 | 112,263 | 111,628 | 100,989 | 97,901 |
| TOTAL | $264,215 | $236,939 | $251,816 | $226,889 | $262,175 |
| Non-Current Liabilities | |||||
| Long Term Debt | 748,662 | 751,381 | 754,102 | 756,826 | 759,552 |
| Other Non-Current Liabilities | 69,931 | 71,980 | 74,715 | 78,220 | 78,402 |
| TOTAL | $853,400 | $860,703 | $865,012 | $875,198 | $873,928 |
| Total Liabilities | $1,117,615 | $1,097,642 | $1,116,828 | $1,102,087 | $1,136,103 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,742 | 50,712 | 50,541 | 50,448 | 50,608 |
| Common Shares | 507 | 507 | 504 | 504 | 506 |
| Retained earnings | 308,898 | 284,017 | 253,168 | 223,785 | 204,364 |
| Other shareholders' equity | -32,705 | -29,518 | -30,381 | -35,799 | -40,255 |
| TOTAL | $893,660 | $864,616 | $817,997 | $775,979 | $729,009 |
| Total Liabilities And Equity | $2,011,275 | $1,962,258 | $1,934,825 | $1,878,066 | $1,865,112 |